Carole Massabeau

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ¹⁸F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Pierre Véra, S. Thureau, Philippe Chaumet‐Riffaud et al. · Journal of Nuclear Medicine · 2017 · 81 citations · Full text

Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort

Clémence Basse, S. Thureau, Suzanna Bota et al. · Journal of Thoracic Oncology · 2017 · 36 citations · Full text

Adaptive Radiotherapy, Surgical Oncology, Radiation Therapy +11

Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study

Florence Dalenc, Virginie Ribet, Ana B. Rossi et al. · European Journal of Cancer Care · 2017 · 35 citations

Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes

Carlos Eduardo Almeida, N. Fournier‐Bidoz, Carole Massabeau et al. · Cancer/Radiothérapie · 2011 · 28 citations

Internal Mammary Nodes, Potential Benefits, Medical Imaging +13

Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial

Pierre Véra, S. Thureau, F. Le Tinier et al. · The Lancet Oncology · 2024 · 28 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +12